Canada Regulators Approve Meridian's C. Difficile Assay
September 30, 2010
Canada Regulators Approve Meridian's C. Difficile Assay
The illumigene C. difficile assay detects the presence of the toxin-producing region from the bacterium and provides highly accurate results in under an hour, according to Meridian.
Full-text access for registered users only.
Existing users login here.
New to GenomeWeb? Register here quickly for free access.
New to GenomeWeb? Register here quickly for free access.
Related Stories
- FDA Clears Meridian's C. difficile Test for Pediatric Patients
March 2, 2011 / GenomeWeb Daily News - Dx Focus: Clinical and Regulatory PCR and Nucleic Acid Testing News
March 2, 2011 / PCR Insider - FDA Recategorizes Meridian's Molecular Strep A and B Assays as 'Moderate Complexity' Tests
March 19, 2013 / GenomeWeb Daily News - US Diagnostics Business Drives up Meridian Bioscience Q1 Revenues 13 Percent
January 23, 2013 / GenomeWeb Daily News - Qiagen Gets China OK for New HPV Test
November 29, 2012 / GenomeWeb Daily News